Related references
Note: Only part of the references are listed.A meta-analysis of gene expression-based biomarkers predicting outcome after tamoxifen treatment in breast cancer
Zsuzsanna Mihaly et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets
A. V. Antonov et al.
CELL DEATH AND DIFFERENTIATION (2013)
Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells
Keith O'Brien et al.
EUROPEAN JOURNAL OF CANCER (2013)
Diagnostic usefulness of 18F-FAMT PET and L-type amino acid transporter 1 (LAT1) expression in oral squamous cell carcinoma
Aiko Nobusawa et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2013)
Clinicopathological Significance of L-type Amino Acid Transporter 1 (LAT1) Expression in Patients with Adenoid Cystic Carcinoma
Kyoichi Kaira et al.
PATHOLOGY & ONCOLOGY RESEARCH (2013)
miRNA-34a is associated with docetaxel resistance in human breast cancer cells
L. Kastl et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Synthetic miR-34a Mimics as a Novel Therapeutic Agent for Multiple Myeloma: In Vitro and In Vivo Evidence
Maria T. Di Martino et al.
CLINICAL CANCER RESEARCH (2012)
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status
Ruth L. Vinall et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
High expression of L-type amino acid transporter 1 (LAT1) predicts poor prognosis in pancreatic ductal adenocarcinomas
Nobuyuki Yanagisawa et al.
JOURNAL OF CLINICAL PATHOLOGY (2012)
miR-34a predicts survival of Ewing's sarcoma patients and directly influences cell chemo-sensitivity and malignancy
Fumihiko Nakatani et al.
JOURNAL OF PATHOLOGY (2012)
MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
Soichiro Yamamura et al.
PLOS ONE (2012)
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
Claire Corcoran et al.
PLOS ONE (2012)
Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes
Deyi Xiao et al.
PLOS ONE (2012)
MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer
Bin Xu et al.
PROSTATE (2012)
miR-146a suppresses the sensitivity to interferon-α in hepatocellular carcinoma cells
Akira Tomokuni et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Androgen Receptor and Nutrient Signaling Pathways Coordinate the Demand for Increased Amino Acid Transport during Prostate Cancer Progression
Qian Wang et al.
CANCER RESEARCH (2011)
Intracellular and Extracellular MicroRNAs in Breast Cancer
Claire Corcoran et al.
CLINICAL CHEMISTRY (2011)
miRWalk - Database: Prediction of possible miRNA binding sites by walking the genes of three genomes
Harsh Dweep et al.
JOURNAL OF BIOMEDICAL INFORMATICS (2011)
Mir-148a Improves Response to Chemotherapy in Sensitive and Resistant Oesophageal Adenocarcinoma and Squamous Cell Carcinoma Cells
Richard Hummel et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2011)
ALIX/AIP1 Is Required for NP Incorporation into Mopeia Virus Z-Induced Virus-Like Particles
Olena Shtanko et al.
JOURNAL OF VIROLOGY (2011)
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
Amanda J. O'Neill et al.
MOLECULAR CANCER (2011)
The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44
Can Liu et al.
NATURE MEDICINE (2011)
miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma
Shyamal D. Weeraratne et al.
NEURO-ONCOLOGY (2011)
Use and Assessment of PSA in Prostate Cancer
Carl K. Gjertson et al.
MEDICAL CLINICS OF NORTH AMERICA (2011)
Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells
Maria Mittelbrunn et al.
NATURE COMMUNICATIONS (2011)
Docetaxel-based combination therapy for castration-resistant prostate cancer
M. D. Galsky et al.
ANNALS OF ONCOLOGY (2010)
Secretion of extracellular hsp90α via exosomes increases cancer cell motility: a role for plasminogen activation
Jessica McCready et al.
BMC CANCER (2010)
MicroRNA and drug resistance
J. Ma et al.
CANCER GENE THERAPY (2010)
Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin
Igor P. Pogribny et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression.
Yasunori Fujita et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
Michele Guescini et al.
JOURNAL OF NEURAL TRANSMISSION (2010)
Tamm-Horsfall protein and urinary exosome isolation
Patricia Fernandez-Llama et al.
KIDNEY INTERNATIONAL (2010)
Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma
Yasuhiro Matsuo et al.
PLOS ONE (2010)
Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells
Lucy Pigati et al.
PLOS ONE (2010)
MiR-34a Attenuates Paclitaxel-Resistance of Hormone-Refractory Prostate Cancer PC3 Cells Through Direct and Indirect Mechanisms
Keitaro Kojima et al.
PROSTATE (2010)
miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression
T. Murata et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Exosomal MicroRNA: A Diagnostic Marker for Lung Cancer
Guilherme Rabinowits et al.
CLINICAL LUNG CANCER (2009)
L-type amino-acid transporter 1 as a novel biomarker for high-grade malignancy in prostate cancer
Takeshi Sakata et al.
PATHOLOGY INTERNATIONAL (2009)
Membrane vesicles as conveyors of immune responses
Clotilde Thery et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells
Yasunori Fujita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
被撤回的出版物: MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer (Retracted article. See vol. 175, pg. 192, 2023)
Douglas D. Taylor et al.
GYNECOLOGIC ONCOLOGY (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Serum MicroRNAs Are Promising Novel Biomarkers
Shlomit Gilad et al.
PLOS ONE (2008)
Detection of microRNA Expression in Human Peripheral Blood Microvesicles
Melissa Piper Hunter et al.
PLOS ONE (2008)
Loss of mir-146a function in hormone-refractory prostate cancer
Shi-Lung Lin et al.
RNA (2008)
Role of the MRP1/ABCC1 multidrug transporter protein in cancer
Marcia Munoz et al.
IUBMB LIFE (2007)
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
Hadi Valadi et al.
NATURE CELL BIOLOGY (2007)
MicroRNA signatures in human cancers
George A. Calin et al.
NATURE REVIEWS CANCER (2006)
Management of advanced prostate cancer after first-line chemotherapy
DR Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
MicroRNA expression profiles classify human cancers
J Lu et al.
NATURE (2005)
Expression of α-, β-, and γ-synuclein in glial tumors and medulloblastomas
KM Fung et al.
ACTA NEUROPATHOLOGICA (2003)
Share Paper
